No Evidence Indicates Famotidine Reduces the Risk of Serious Disease in COVID-19 Patients After Propensity Score Matching: Meta-Analysis and Systematic Reviews

Detalles Bibliográficos
Autores principales: Li, Weizheng, Dong, Yongxue, Lei, Xianmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409265/
https://www.ncbi.nlm.nih.gov/pubmed/34471967
http://dx.doi.org/10.1007/s10620-021-07214-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409265/
https://www.ncbi.nlm.nih.gov/pubmed/34471967
http://dx.doi.org/10.1007/s10620-021-07214-9

Ejemplares similares